New Imaging Method to Localize Tumors

The carrier molecule accumulates where the bispecific antibody has localized. Once the label shows this location of disease, treatment can be administered by surgery or radiation. The method, developed by Immunomedics, Inc. (Morris Plains, NJ, USA), is the subject of several US patents.

Immunomedics is a biopharmaceutical company focused on diagnostic imaging and therapeutic products for the detection and treatment of cancer and infectious diseases. Integral to these products are highly specific monoclonal antibodies and antibody fragments designed to deliver radioisotopes and chemotherapeutic agents to tumors and sites of infection.

"Endoscopic and laparoscopic methods of performing biopsies and surgery are now very commonplace, so this new technology should fit in well with these approaches,” explained Cynthia L. Sullivan, president and CEO of Immunomedics.




Related Links:
Immunomedics